Stocks and Investing
Stocks and Investing
Mon, January 10, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Rick Bienkowski Maintained (BEAM) at Buy with Increased Target to $121 on, Jan 10th, 2022
Rick Bienkowski of SVB Leerink, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Increased Target from $116 to $121 on, Jan 10th, 2022.
Rick has made no other calls on BEAM in the last 4 months.
There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 0 agree with Rick's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Rick
- Debjit Chattopadhyay of "Guggenheim" Initiated at Strong Buy and Held Target at $130 on, Wednesday, January 5th, 2022
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $150 on, Friday, September 10th, 2021
Contributing Sources